Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8443354 | European Journal of Cancer | 2014 | 11 Pages |
Abstract
In the evolving landscape of multimodality therapy, selective hepatic resection for CRLM patients with EHD is feasible with potential impact on survival. Patients with minimal liver disease and EHD in the lung achieve the best outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael Hwang, Thejus T. Jayakrishnan, Danielle E. Green, Ben George, James P. Thomas, Ryan T. Groeschl, Beth Erickson, Sam G. Pappas, T. Clark Gamblin, Kiran K. Turaga,